These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1100 related articles for article (PubMed ID: 17056094)
21. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311 [TBL] [Abstract][Full Text] [Related]
22. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC; Chen PC; Ho DM Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [TBL] [Abstract][Full Text] [Related]
24. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740 [TBL] [Abstract][Full Text] [Related]
25. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University]. Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540 [TBL] [Abstract][Full Text] [Related]
26. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276 [TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity of DNA repair gene, hOGG1, in renal cell carcinoma but not in renal papillary adenoma. Gokden N; Li L; Zhang H; Schafer RF; Schichman S; Scott MA; Smoller BR; Fan CY Pathol Int; 2008 Jun; 58(6):339-43. PubMed ID: 18477212 [TBL] [Abstract][Full Text] [Related]
28. Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma. Bhatnagar R; Alexiev BA Int J Surg Pathol; 2012 Feb; 20(1):19-28. PubMed ID: 21791489 [TBL] [Abstract][Full Text] [Related]
29. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469 [TBL] [Abstract][Full Text] [Related]
30. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Khurana KK; Truong LD; Verani RR Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084 [TBL] [Abstract][Full Text] [Related]
31. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Olgac S; Hutchinson B; Tickoo SK; Reuter VE Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894 [TBL] [Abstract][Full Text] [Related]
32. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792 [TBL] [Abstract][Full Text] [Related]
33. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984 [TBL] [Abstract][Full Text] [Related]
35. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306 [TBL] [Abstract][Full Text] [Related]
36. Expression of vitamin D3 receptor in kidney tumors. Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927 [TBL] [Abstract][Full Text] [Related]
37. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma. Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433 [TBL] [Abstract][Full Text] [Related]
39. [Multicentricity and concomitant tumors in renal cell carcinoma: analysis by serial section of resected kidneys]. Saiki S; Kinouchi T; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T Hinyokika Kiyo; 1995 Sep; 41(9):725-9. PubMed ID: 7484540 [TBL] [Abstract][Full Text] [Related]
40. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia. Hosseini M; Antic T; Paner GP; Chang A Hum Pathol; 2014 Jul; 45(7):1406-13. PubMed ID: 24775605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]